1,444 results on '"Kung, Andrew L."'
Search Results
2. Lessons learned from 20 years of preclinical testing in pediatric cancers
3. Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm
4. Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients
5. Clonal evolution during metastatic spread in high-risk neuroblastoma
6. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
7. Author Correction: Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
8. Association between busulfan exposure and survival in patients undergoing a CD34+ selected stem cell transplantation
9. Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors
10. Antithymocyte globulin exposure in CD34+ T-cell–depleted allogeneic hematopoietic cell transplantation
11. Therapeutic targeting of ATR in alveolar rhabdomyosarcoma
12. Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation
13. STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma
14. Overcoming clinical resistance to EZH2 inhibition using rational epigenetic combination therapy
15. Regulatory T Cell Reconstitution Is Associated with Acute Graft-Versus-Host Disease in Pediatric and Young Adult Hematopoietic Cell Transplant Recipients
16. Predictors for Recent Thymic Emigrant T Cell Reconstitution after Hematopoietic Cell Transplantation
17. Abstract PR01: Identification and pharmacological targeting of treatment-resistant, stem-like breast cancer cells for combination therapy
18. High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines
19. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
20. BPTF regulates growth of adult and pediatric high-grade glioma through the MYC pathway
21. Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
22. Abstract B023: SMARCAL1 is a novel candidate therapeutic target for ALT-positive osteosarcoma
23. A Bayesian active learning platform for scalable combination drug screens
24. Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy
25. BRCA1-IRIS promotes human tumor progression through PTEN blockade and HIF-1α activation
26. BET bromodomain proteins regulate enhancer function during adipogenesis
27. Recurrent EML4–NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy
28. Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
29. Activation of Apoptosis in vivo by a Hydrocarbon-Stapled BH3 Helix
30. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma
31. Targeted Polymersome Delivery of a Stapled Peptide for Drugging the Tumor Protein p53:BCL-2-Family Axis in Diffuse Large B-Cell Lymphoma
32. Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations
33. A Small-Molecule Antagonist of CXCR4 Inhibits Intracranial Growth of Primary Brain Tumors
34. Distinct Roles for CREB-Binding Protein and p300 in Hematopoietic Stem Cell Self-Renewal
35. Structural Basis for Recruitment of CBP/p300 by Hypoxia-Inducible Factor-1α
36. Isabl Platform, a digital biobank for processing multimodal patient data
37. Role of T-bet in Commitment of T H1 Cells before IL-12-Dependent Selection
38. A Stimulus-Specific Role for CREB-Binding Protein (CBP) in T Cell Receptor-Activated Tumor Necrosis Factor α Gene Expression
39. A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.
40. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
41. Clonal hematopoiesis in survivors of childhood cancer
42. Supplementary Table S2 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
43. Data from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
44. Supplementary Figure S1 from Overcoming Barriers to Tumor Genomic Profiling through Direct-to-Patient Outreach
45. A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
46. Risk Factors and Utility of a Risk-Based Algorithm for Monitoring Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections in Pediatric Recipients after Allogeneic Hematopoietic Cell Transplantation
47. Survival Impact of Early Post-Transplant Toxicities in Pediatric and Adolescent Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Malignant and Nonmalignant Diseases: Recognizing Risks and Optimizing Outcomes
48. Abstract 849: Evaluation of a transcriptomics-based precision oncology platform for patient-therapy alignment in treatment resistant malignancies
49. Abstract 6541: Geometry of gene expression network reveals potential novel indicator in Ewing sarcoma
50. Abstract 2149: A whole genome sequencing classifier of homologous recombination deficiency
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.